Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Artivion, Inc. stock logo
AORT
Artivion
$25.00
+1.3%
$27.20
$19.36
$32.33
$1.05B1.79277,687 shs728,611 shs
ArriVent BioPharma, Inc. stock logo
AVBP
ArriVent BioPharma
$18.00
-0.2%
$23.90
$14.35
$36.37
$612.29M1163,660 shs277,235 shs
MultiPlan Co. stock logo
MPLN
MultiPlan
$20.70
+0.3%
$21.53
$4.80
$35.96
$334.74M0.13109,278 shs42,106 shs
Varex Imaging Co. stock logo
VREX
Varex Imaging
$11.43
$12.99
$10.19
$18.30
$470.92M0.65537,711 shs225,388 shs
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Artivion, Inc. stock logo
AORT
Artivion
+1.44%+1.25%-0.60%-10.97%+20.25%
ArriVent BioPharma, Inc. stock logo
AVBP
ArriVent BioPharma
-0.17%-1.53%-18.29%-34.47%0.00%
MultiPlan Co. stock logo
MPLN
MultiPlan
+0.34%-2.59%-1.38%+59.85%+2,069,999,900.00%
Varex Imaging Co. stock logo
VREX
Varex Imaging
0.00%-5.38%-10.98%-20.68%-36.54%
Remove Ads
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Artivion, Inc. stock logo
AORT
Artivion
3.4254 of 5 stars
3.53.00.00.02.32.51.9
ArriVent BioPharma, Inc. stock logo
AVBP
ArriVent BioPharma
1.3434 of 5 stars
3.61.00.00.02.30.00.0
MultiPlan Co. stock logo
MPLN
MultiPlan
1.8667 of 5 stars
3.00.00.00.02.61.70.6
Varex Imaging Co. stock logo
VREX
Varex Imaging
4.5058 of 5 stars
3.54.00.04.02.70.81.9
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Artivion, Inc. stock logo
AORT
Artivion
3.00
Buy$31.4025.60% Upside
ArriVent BioPharma, Inc. stock logo
AVBP
ArriVent BioPharma
3.17
Buy$39.00116.67% Upside
MultiPlan Co. stock logo
MPLN
MultiPlan
2.00
Hold$26.2526.81% Upside
Varex Imaging Co. stock logo
VREX
Varex Imaging
3.00
Buy$22.5096.85% Upside

Current Analyst Ratings Breakdown

Latest AVBP, MPLN, AORT, and VREX Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
3/20/2025
ArriVent BioPharma, Inc. stock logo
AVBP
ArriVent BioPharma
B. Riley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$37.00
3/19/2025
ArriVent BioPharma, Inc. stock logo
AVBP
ArriVent BioPharma
B. Riley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
3/10/2025
ArriVent BioPharma, Inc. stock logo
AVBP
ArriVent BioPharma
Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$45.00
3/7/2025
ArriVent BioPharma, Inc. stock logo
AVBP
ArriVent BioPharma
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$39.00 ➝ $39.00
2/25/2025
Artivion, Inc. stock logo
AORT
Artivion
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$33.00 ➝ $30.00
2/25/2025
Artivion, Inc. stock logo
AORT
Artivion
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$34.00 ➝ $32.00
2/7/2025
Varex Imaging Co. stock logo
VREX
Varex Imaging
Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$30.00 ➝ $23.00
2/7/2025
Varex Imaging Co. stock logo
VREX
Varex Imaging
B. Riley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$21.00 ➝ $22.00
1/28/2025
Artivion, Inc. stock logo
AORT
Artivion
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$34.00 ➝ $34.00
1/22/2025
ArriVent BioPharma, Inc. stock logo
AVBP
ArriVent BioPharma
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$36.00 ➝ $39.00
1/10/2025
MultiPlan Co. stock logo
MPLN
MultiPlan
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$10.00 ➝ $12.50
(Data available from 4/3/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Artivion, Inc. stock logo
AORT
Artivion
$388.54M2.71$0.68 per share36.78$6.87 per share3.64
ArriVent BioPharma, Inc. stock logo
AVBP
ArriVent BioPharma
N/AN/AN/AN/A($4.79) per shareN/A
MultiPlan Co. stock logo
MPLN
MultiPlan
$930.62M0.36$12.62 per share1.64$105.45 per share0.20
Varex Imaging Co. stock logo
VREX
Varex Imaging
$820.80M0.57$1.22 per share9.35$13.45 per share0.85
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Artivion, Inc. stock logo
AORT
Artivion
-$30.69M-$0.31N/A50.00N/A-0.22%5.15%1.91%5/5/2025 (Estimated)
ArriVent BioPharma, Inc. stock logo
AVBP
ArriVent BioPharma
-$69.33M-$2.57N/AN/AN/AN/A-43.89%-29.67%5/14/2025 (Estimated)
MultiPlan Co. stock logo
MPLN
MultiPlan
-$91.70M-$101.54N/AN/AN/A-163.30%-12.14%-1.84%5/6/2025 (Estimated)
Varex Imaging Co. stock logo
VREX
Varex Imaging
-$47.70M-$1.17N/A20.05N/A-5.79%4.00%1.81%5/1/2025 (Estimated)

Latest AVBP, MPLN, AORT, and VREX Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/1/2025N/A
Varex Imaging Co. stock logo
VREX
Varex Imaging
$0.14N/AN/AN/A$206.76 millionN/A
3/3/2025Q4 2024
ArriVent BioPharma, Inc. stock logo
AVBP
ArriVent BioPharma
-$0.78-$0.60+$0.18-$0.61N/AN/A
2/24/2025Q4 2024
Artivion, Inc. stock logo
AORT
Artivion
$0.12-$0.39-$0.51-$0.39$100.82 million$97.31 million
2/6/2025Q1 2025
Varex Imaging Co. stock logo
VREX
Varex Imaging
$0.04$0.07+$0.03-$0.01$202.15 millionN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Artivion, Inc. stock logo
AORT
Artivion
N/AN/AN/AN/AN/A
ArriVent BioPharma, Inc. stock logo
AVBP
ArriVent BioPharma
N/AN/AN/AN/AN/A
MultiPlan Co. stock logo
MPLN
MultiPlan
N/AN/AN/AN/AN/A
Varex Imaging Co. stock logo
VREX
Varex Imaging
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Artivion, Inc. stock logo
AORT
Artivion
0.71
1.88
1.33
ArriVent BioPharma, Inc. stock logo
AVBP
ArriVent BioPharma
N/A
19.28
19.28
MultiPlan Co. stock logo
MPLN
MultiPlan
21.73
1.05
1.05
Varex Imaging Co. stock logo
VREX
Varex Imaging
1.02
4.36
2.50

Institutional Ownership

CompanyInstitutional Ownership
Artivion, Inc. stock logo
AORT
Artivion
86.37%
ArriVent BioPharma, Inc. stock logo
AVBP
ArriVent BioPharma
9.48%
MultiPlan Co. stock logo
MPLN
MultiPlan
87.15%
Varex Imaging Co. stock logo
VREX
Varex Imaging
N/A

Insider Ownership

CompanyInsider Ownership
Artivion, Inc. stock logo
AORT
Artivion
8.10%
ArriVent BioPharma, Inc. stock logo
AVBP
ArriVent BioPharma
N/A
MultiPlan Co. stock logo
MPLN
MultiPlan
8.00%
Varex Imaging Co. stock logo
VREX
Varex Imaging
4.30%
CompanyEmployeesShares OutstandingFree FloatOptionable
Artivion, Inc. stock logo
AORT
Artivion
1,30042.05 million38.52 millionOptionable
ArriVent BioPharma, Inc. stock logo
AVBP
ArriVent BioPharma
4034.02 millionN/AN/A
MultiPlan Co. stock logo
MPLN
MultiPlan
17016.17 million14.88 millionOptionable
Varex Imaging Co. stock logo
VREX
Varex Imaging
2,30041.20 million39.43 millionOptionable

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Artivion stock logo

Artivion NYSE:AORT

$25.00 +0.33 (+1.34%)
Closing price 04/2/2025 03:58 PM Eastern
Extended Trading
$23.80 -1.20 (-4.80%)
As of 07:14 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Artivion, Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company provides BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial patch; and aortic arch stent grafts including E-vita Open Plus and E-vita Open Neo. It offers E-xtra design engineering systems for the treatment of aortic vascular diseases; E-nside, an off-the-shelf stent graft for the treatment of thoraco-abdominal disease; E-vita THORACIC 3G for the endovascular treatment of thoracic aortic aneurysms; E-ventus BX, a balloon-expandable peripheral stent graft for the endovascular treatment of renal and pelvic arteries; E-liac to treat aneurysmal iliac arteries, and aneurysmal iliac side branches; and E-tegra, a stent graft system for the treatment of infrarenal abdominal aortic aneurysms. In addition, the company offers synthetic vascular grafts for use in open aortic and peripheral vascular surgical procedures; PerClot, an absorbable powdered hemostat for use in surgical procedures; cardiac laser therapy products for angina treatment; CryoVein femoral vein and CryoArtery femoral artery vascular preservation services; On-X prosthetic aortic and mitral heart valves and the On-X ascending aortic prosthesis; CarbonAid CO2 diffusion catheters and Chord-X ePTFE sutures for mitral chordal replacement; and ascyrus medical dissection stents, as well as pyrolytic carbon coating services to medical device manufacturers. It serves physicians, hospitals, and other healthcare facilities, as well as cardiac, vascular, thoracic, and general surgeons. The company was formerly known as CryoLife, Inc. and changed its name to Artivion, Inc. in January 2022. Artivion, Inc. was incorporated in 1984 and is headquartered in Kennesaw, Georgia.

ArriVent BioPharma stock logo

ArriVent BioPharma NASDAQ:AVBP

$18.00 -0.03 (-0.17%)
Closing price 04/2/2025 04:00 PM Eastern
Extended Trading
$17.59 -0.41 (-2.28%)
As of 06:52 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ArriVent BioPharma, Inc. operates as a clinical-stage biopharmaceutical company that engages in the identification, development, and commercialization of medicines for the unmet medical needs of patients with cancers in the United States. It also engages in the development and commercialization of targeted cancer therapies for non-small cell lung cancer (NSCLC) and other solid tumors. In addition, the company develops Furmonertinib, a third-generation tyrosine kinase inhibitor that is in multiple clinical trials across a range of epidermal growth factor receptor mutations (EFGRm) in non-small cell lung cancer (NSCLC), including a phase 3 clinical trial for treatment of patients with metastatic EFGRm NSCLC; phase 1b clinical trial for treatment of patients with NSCLC with other EGFR mutations and NSCLC with HER2 Exon 20 insertion mutations; and ARR-002. It has strategic collaborations with Aarvik Therapeutics Inc. to discover and develop antibody drug conjugates (ADCs) with improved activity and safety over single target bivalent ADCs; and Shanghai Allist Pharmaceuticals Co., Ltd. to develop and commercialize Furmonertinib. The company was incorporated in 2021 and is based in Newtown Square, Pennsylvania.

MultiPlan stock logo

MultiPlan NYSE:MPLN

$20.70 +0.07 (+0.34%)
As of 04/1/2025

MultiPlan Corporation, together with its subsidiaries, provides data analytics and technology-enabled cost management, payment, and revenue integrity solutions to the healthcare industry in the United States. The company offers analytics-based services that reduce medical costs, through data-driven algorithms and insights that detect claims over-charges and negotiate or recommend reimbursement; and network-based services that provide contracted discounts with healthcare providers, as well as outsourced network development and management services. It provides payment and revenue integrity services, such as identifying and removing improper and unnecessary charges paid during the claim, as well as services to identify and help restore and preserve underpaid premium dollars. In addition, the company offers data and decision science services including a suite of solutions that apply modern methods of data science to produce descriptive, predictive, and prescriptive analytics that drive optimized benefit plan design, support decision-making, improve clinical outcomes, and reduce the total cost of care; and business-to-business healthcare payments and other services. It serves national and regional insurance companies, Blue Cross and Blue Shield plans, provider-sponsored and independent health plans, TPAs, self-insured health plans, property and casualty insurers, bill review companies, and other companies involved in the claim adjudication process. MultiPlan Corporation was founded in 1980 and is headquartered in New York, New York.

Varex Imaging stock logo

Varex Imaging NASDAQ:VREX

$11.43 0.00 (0.00%)
Closing price 04/2/2025 04:00 PM Eastern
Extended Trading
$11.38 -0.05 (-0.48%)
As of 08:00 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Varex Imaging Corporation designs, manufactures, and sells X-ray imaging components. The company operates through two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components, comprising X-ray tubes, digital detectors and accessories, ionization chambers, high voltage connectors, image-processing software and workstations, 3D reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, and heat exchangers. This segment's products are used in a range of applications, including CT, mammography, oncology, cardiac, surgery, dental, and other diagnostic radiography uses. The Industrial segment designs, develops, manufactures, sells, and services Linatron X-ray linear accelerators, X-ray tubes, digital detectors, high voltage connectors, and coolers for use in security and inspection applications, such as baggage screening at airports, cargo screening at ports and borders, and nondestructive testing, irradiation, and inspection in various applications. The company sells its products through imaging system original equipment manufacturers, independent service companies, and distributors, as well as directly to end-users. It has operations in North America, South America, Europe, Russia, the Middle East, India, Africa, Asia, and Australia. Varex Imaging Corporation was incorporated in 2016 and is headquartered in Salt Lake City, Utah.